We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
Cap. Flow
+$857M
Cap. Flow %
6.4%
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$175M
2
LOW icon
Lowe's Companies
LOW
+$167M
3
AZO icon
AutoZone
AZO
+$127M
4
NTRS icon
Northern Trust
NTRS
+$127M
5
MRK icon
Merck
MRK
+$118M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$133M
2
RAI
Reynolds American Inc
RAI
+$126M
3
KEY icon
KeyCorp
KEY
+$113M
4
WMT icon
Walmart Inc
WMT
+$110M
5
OA
Orbital ATK, Inc.
OA
+$108M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Industrials 14.06%
3 Consumer Discretionary 12.07%
4 Healthcare 11.22%
5 Financials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALA icon
326
KALA BIO
KALA
$14.2M
$2.91M 0.02%
+51
New +$2.8M
ATRA icon
327
Atara Biotherapeutics
ATRA
$74.3M
$2.89M 0.02%
6,995
+125
+2% +$47.1K
PK icon
328
Park Hotels & Resorts
PK
$2.89B
$2.85M 0.02%
103,297
-1,926,228
-95% -$51.5M
RETA
329
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.83M 0.02%
+91,048
New +$2.74M
TXMD icon
330
TherapeuticsMD
TXMD
$24.2M
$2.81M 0.02%
+10,632
New +$3.07M
XLRN
331
DELISTED
Acceleron Pharma
XLRN
$2.8M 0.02%
+75,000
New +$2.6M
QEP
332
DELISTED
QEP RESOURCES, INC.
QEP
$2.74M 0.02%
320,190
-1,705,365
-84% -$13.9M
ARGX icon
333
argenx
ARGX
$54.8B
$2.74M 0.02%
121,313
+2,167
+2% +$45.2K
CSLT
334
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.73M 0.02%
634,885
+11,338
+2% +$46.7K
ZLAB icon
335
Zai Lab
ZLAB
$2.34B
$2.7M 0.02%
+100,000
New +$2.79M
PETQ
336
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2.65M 0.02%
+97,746
New +$2.36M
TTI icon
337
CALL
TETRA Technologies
TTI
$1.27B
$2.65M 0.02%
925,000
– –
TIG
338
DELISTED
TiGenix American Depositary Shares
TIG
$2.51M 0.02%
105,372
+1,885
+2% +$41.7K
AKBA icon
339
Akebia Therapeutics
AKBA
$264M
$2.5M 0.02%
127,274
+2,274
+2% +$35K
V icon
340
Visa
V
$692B
$2.47M 0.02%
23,452
-3,890
-14% -$395K
DVA icon
341
DaVita
DVA
$11.5B
$2.46M 0.02%
41,490
-603,246
-94% -$36.3M
LII icon
342
Lennox International
LII
$15.1B
$2.46M 0.02%
+13,744
New +$2.36M
AAL icon
343
American Airlines Group
AAL
$10.6B
$2.41M 0.02%
+50,723
New +$2.45M
IPGP icon
344
IPG Photonics
IPGP
$3.69B
$2.38M 0.02%
12,877
+5,642
+78% +$937K
HXL icon
345
Hexcel
HXL
$7.79B
$2.36M 0.02%
+41,134
New +$2.22M
OMED
346
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.36M 0.02%
521,883
+9,320
+2% +$37.8K
BCRX icon
347
BioCryst Pharmaceuticals
BCRX
$2.38B
$2.36M 0.02%
+450,000
New +$2.3M
KREF
348
KKR Real Estate Finance Trust
KREF
$478M
$2.35M 0.02%
111,803
-88,197
-44% -$1.84M
LOXO
349
DELISTED
Loxo Oncology, Inc
LOXO
$2.35M 0.02%
25,452
-24,548
-49% -$1.91M
NCNA
350
NuCana
NCNA
$5.66M
$2.3M 0.02%
+25
New +$2.16M
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q3 2017 Portfolio in Review

As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.

  • Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
  • Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
  • Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
  • Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
  • Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.

Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.